Regenerative therapies like hyperdiluted CaHA show promise for treating mild to moderate hair loss.
1 citations
,
August 2024 in “Lasers in Surgery and Medicine” Calcium hydroxylapatite can be successfully integrated into healing skin and stimulates collagen.
February 2026 in “Plastic and Aesthetic Research” Regenerative aesthetic medicine aims to restore tissue function, but needs more consistent evidence and standardized practices.
November 2025 in “Scientia Pharmaceutica” The document reviews the use of injectable biostimulatory agents like PLLA, PCL, and CaHA in regenerative aesthetics, focusing on their ability to stimulate collagen production and adipocyte activity, which improves skin volume, elasticity, and texture. PLLA is noted for its long-term effects on dermal thickness and elasticity, while PCL acts as a scaffold for stem cells, enhancing adipogenesis and dermal remodeling. CaHA provides immediate volumization with long-term benefits. Despite promising results, the review highlights the need for standardized protocols and large-scale studies to confirm the efficacy and safety of these treatments in aesthetic applications.
September 2023 in “Hair transplant forum international” Temporary hair loss can happen after a facial rejuvenation procedure due to blood flow blockage caused by a certain filler.